Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases

SIMPLE SUMMARY: HER2+ breast cancer patients are treated with agents that tag HER2+ tumour cells for elimination by the immune system, down-modulate HER2 activity and/or block the formation of HER2 dimers, including the neuregulin-1 receptor, HER2-HER3. HER2-targeted therapies prolong survival by lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Malcolm, Nguyen, Tam H., Niland, Colleen, Reid, Lynne E., Jat, Parmjit S., Saunus, Jodi M., Lakhani, Sunil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833370/
https://www.ncbi.nlm.nih.gov/pubmed/35158800
http://dx.doi.org/10.3390/cancers14030533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833370/
https://www.ncbi.nlm.nih.gov/pubmed/35158800
http://dx.doi.org/10.3390/cancers14030533

Ejemplares similares